Confirming previous findings involving GSK-3β inhibitors [26,27], we found that pharmacological inhibition of the GSK-3β activity with C11 improved or even restored neuronal maturation and connectivity in in vitro and in vivo models of CDD. Here, GSK3B is linked to craniodiaphyseal dysplasia.